TGFB1 and adenoma: Additionally, CMS2 adenomas expressed genes involved in epithelial–mesenchymal transition, the transforming growth factor (TGF)‐β signalling pathway, and the development of muscles, which are processes typically assigned to CMS4 CRCs, and genes involved in the immune response (coagulation), which are characteristic of CMS1 CRCs.